Medtronic Plc (MDT) Holder Washington Trust Bank Boosted Stake; Alexion Pharmaceuticals (ALXN) Shares Declined While Nine Masts Capital LTD Lifted Its Position

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Logo

Chao Ku increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 5450.44% based on its latest 2018Q1 regulatory filing with the SEC. Nine Masts Capital Ltd bought 24,527 shares as the company’s stock declined 2.96% with the market. The hedge fund run by Chao Ku held 24,977 shares of the health care company at the end of 2018Q1, valued at $2.78M, up from 450 at the end of the previous reported quarter. Nine Masts Capital Ltd who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be bullish on the $25.92B market cap company. The stock increased 0.65% or $0.75 during the last trading session, reaching $116.48. About 1.15 million shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has risen 19.53% since May 31, 2017 and is uptrending. It has outperformed by 6.96% the S&P500.

Washington Trust Bank increased its stake in Medtronic Plc (MDT) by 5.21% based on its latest 2018Q1 regulatory filing with the SEC. Washington Trust Bank bought 4,321 shares as the company’s stock rose 4.71% while stock markets declined. The institutional investor held 87,229 shares of the electromedical & electrotherapeutic apparatus company at the end of 2018Q1, valued at $7.00M, up from 82,908 at the end of the previous reported quarter. Washington Trust Bank who had been investing in Medtronic Plc for a number of months, seems to be bullish on the $116.31 billion market cap company. The stock increased 0.59% or $0.5 during the last trading session, reaching $85.89. About 4.24 million shares traded. Medtronic plc (NYSE:MDT) has risen 0.84% since May 31, 2017 and is uptrending. It has underperformed by 11.73% the S&P500.

Nine Masts Capital Ltd, which manages about $653.66 million US Long portfolio, decreased its stake in First Tr Exchange (FPE) by 67,356 shares to 15,744 shares, valued at $306,000 in 2018Q1, according to the filing. It also reduced its holding in Spdr S&P 500 Etf Tr (Call) (SPY) by 136,270 shares in the quarter, leaving it with 2,500 shares, and cut its stake in China Mobile Limited (NYSE:CHL).

More important recent Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) news were published by: Benzinga.com which released: “Benzinga’s Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck’s Cancer Drug Review …” on May 25, 2018, also Benzinga.com published article titled: “Benzinga’s Insider Buys Of The Week: Alexion Pharmaceuticals, Sohu.com And More”, Streetinsider.com published: “Vertex Pharma (VRTX), Alexion Pharma (ALXN) Least Impacted from Trump Drug Policies – RBC” on May 15, 2018. More interesting news about Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was released by: Pehub.com and their article: “VC-backed Prevail Therapeutics beefs up board with new addition” with publication date: May 25, 2018.

Among 29 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 25 have Buy rating, 0 Sell and 4 Hold. Therefore 86% are positive. Alexion Pharmaceuticals Inc. had 110 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Leerink Swann given on Friday, February 9. The rating was upgraded by FBR Capital to “Mkt Perform” on Friday, October 28. The rating was maintained by UBS on Friday, July 31 with “Buy”. The company was maintained on Friday, October 20 by BMO Capital Markets. Raymond James maintained the shares of ALXN in report on Monday, April 23 with “Buy” rating. The rating was initiated by Deutsche Bank with “Buy” on Thursday, November 3. The rating was upgraded by Robert W. Baird to “Outperform” on Monday, December 18. The company was maintained on Tuesday, September 12 by Stifel Nicolaus. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Outperform” rating by RBC Capital Markets on Wednesday, July 13. The firm has “Buy” rating given on Friday, July 31 by Brean Capital.

Since January 2, 2018, it had 1 buy, and 12 selling transactions for $3.41 million activity. $192,028 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares were sold by Goff Brian. HANTSON LUDWIG had sold 2,553 shares worth $310,521. O’Neill Julie sold $194,723 worth of stock or 1,625 shares. 1,459 Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares with value of $169,696 were sold by Franchini Indrani Lall. $1.21 million worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was bought by COUGHLIN CHRISTOPHER J on Monday, April 30. Wagner Heidi L sold $76,805 worth of stock or 655 shares.

Investors sentiment decreased to 1 in Q1 2018. Its down 0.03, from 1.03 in 2017Q4. It dived, as 43 investors sold ALXN shares while 184 reduced holdings. 60 funds opened positions while 167 raised stakes. 200.94 million shares or 1.68% less from 204.38 million shares in 2017Q4 were reported. Wetherby Asset Management reported 9,832 shares or 0.15% of all its holdings. 3.51M were accumulated by Tiaa Cref Investment Mngmt Lc. Art Advisors Limited Company owns 59,800 shares or 0.27% of their US portfolio. Advisory Service Networks Limited Com holds 0% or 360 shares in its portfolio. Private Tru Na invested in 8,263 shares. Quantitative Systematic Strategies Limited has 3,314 shares. Iridian Asset Mngmt Limited Liability Com Ct has 9,941 shares for 0.01% of their portfolio. Capital One Natl Association invested 0.06% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Blair William & Il owns 2,861 shares for 0% of their portfolio. The New York-based Blackrock has invested 0.1% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Glenmede Na invested in 0% or 8,044 shares. Moreover, Columbus Circle Investors has 0.43% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 188,836 shares. Mirae Asset Global Invs, Korea-based fund reported 26,331 shares. Quantbot Techs Lp owns 12,764 shares or 0.12% of their US portfolio. Brinker Inc reported 5,685 shares.

More notable recent Medtronic plc (NYSE:MDT) news were published by: Seekingalpha.com which released: “Medtronic plc 2018 Q4 – Results – Earnings Call Slides” on May 24, 2018, also Benzinga.com with their article: “Earnings Roundup for Medtronic” published on May 23, 2018, Globenewswire.com published: “Medtronic to Participate in Goldman Sachs Global Healthcare Conference” on May 29, 2018. More interesting news about Medtronic plc (NYSE:MDT) were released by: Seekingalpha.com and their article: “Medtronic plc (MDT) CEO Omar Ishrak on Q4 2018 Results – Earnings Call Transcript” published on May 24, 2018 as well as Seekingalpha.com‘s news article titled: “Medtronic Should Focus On Aggressive Deleveraging” with publication date: May 15, 2018.

Washington Trust Bank, which manages about $697.09M US Long portfolio, decreased its stake in Abbvie Inc (NYSE:ABBV) by 9,288 shares to 108,226 shares, valued at $10.24 million in 2018Q1, according to the filing. It also reduced its holding in Entergy Corp (NYSE:ETR) by 4,633 shares in the quarter, leaving it with 684 shares, and cut its stake in Lockheed Martin Corp (NYSE:LMT).

Among 29 analysts covering Medtronic (NYSE:MDT), 19 have Buy rating, 0 Sell and 10 Hold. Therefore 66% are positive. Medtronic had 86 analyst reports since August 10, 2015 according to SRatingsIntel. Wedbush maintained the shares of MDT in report on Wednesday, June 1 with “Neutral” rating. The stock has “Outperform” rating by William Blair on Thursday, July 6. The firm has “Equal-Weight” rating given on Thursday, March 29 by Morgan Stanley. The rating was maintained by SunTrust with “Buy” on Friday, November 17. The company was maintained on Monday, October 9 by Leerink Swann. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, April 19 report. The stock of Medtronic plc (NYSE:MDT) has “Buy” rating given on Tuesday, June 7 by Needham. The firm has “Buy” rating by Jefferies given on Tuesday, September 26. Bank of America downgraded Medtronic plc (NYSE:MDT) on Tuesday, January 3 to “Neutral” rating. Deutsche Bank maintained the stock with “Buy” rating in Monday, July 31 report.

Investors sentiment increased to 1.08 in 2018 Q1. Its up 0.06, from 1.02 in 2017Q4. It is positive, as 80 investors sold MDT shares while 383 reduced holdings. 88 funds opened positions while 414 raised stakes. 1.04 billion shares or 0.00% more from 1.04 billion shares in 2017Q4 were reported. Dekabank Deutsche Girozentrale reported 858,888 shares. Pinebridge Invests LP invested in 0.67% or 350,147 shares. Roffman Miller Associates Pa, a Pennsylvania-based fund reported 249,471 shares. Balasa Dinverno Foltz Llc invested in 0.04% or 2,947 shares. Moreover, Cornerstone Investment Partners Limited Liability Corp has 2.55% invested in Medtronic plc (NYSE:MDT) for 726,834 shares. The New York-based Community Savings Bank Na has invested 0.15% in Medtronic plc (NYSE:MDT). Horizon Invests Limited Liability Corp owns 0.05% invested in Medtronic plc (NYSE:MDT) for 13,259 shares. Paradigm Asset Management Lc owns 1,200 shares. Dodge & Cox holds 1.21% of its portfolio in Medtronic plc (NYSE:MDT) for 18.72M shares. Ancora Advisors Ltd Company has invested 0.27% of its portfolio in Medtronic plc (NYSE:MDT). Tiverton Asset Management Limited Co accumulated 19,848 shares or 0.11% of the stock. Shine Inv Advisory Svcs Inc has invested 0.09% in Medtronic plc (NYSE:MDT). M Secs, a Oregon-based fund reported 8,853 shares. Calamos Wealth Mgmt Ltd Com holds 0.05% or 5,177 shares. Burney holds 11,070 shares.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Institutional Positions Chart